TELA Bio TELA 深 沪
等待开盘 08-11 09:30:00 美东时间
0.93
+0.060
+6.91%
华盛通- 最 高0.9975
- 今 开0.879
- 成交量 38.28万股
- 最 低 0.8745
- 昨 收 0.8699
- 总市值 4163.25万
- 52周最高 2.00
- 市盈率 静 --
- 换手率 0.86%
- 52周最低 0.5011
- 委 比 92.49%
- 总股本 4476.61万
- 历史最高 23.545
- 量 比 1.65
- 振 幅 14.14%
- 历史最低 0.5011
- 每 手 1
- 风险率 0.33%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
TELA Bio, Inc. announced that its Board of Directors approved inducement grants of stock options and restricted stock units to its newly-hired Chief Executive Officer, Heather Getz, and 11 new employees. The grants include options to purchase 2,370,000 shares and restricted stock units covering 500,000 shares for Ms. Getz, as well as restricted stock units for 95,500 shares for the new employees. The stock options have an exercise price of $0.74 ...
08-05 20:05
TELA Bio Appoints Heather Getz CEO, Effective Immediately
TELA Bio, Inc. ("TELA Bio" or the "Company"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, announced that the Board of Directors (the "Board") has appointed Heather Getz as Chief Executive Officer and Director, effective today.
08-04 19:11
TELA Bio to Participate in the Canaccord Genuity 46th Annual Growth Conference
TELA Bio, Inc. (NASDAQ: TELA) announced its participation in the Canaccord Genuity 46th Annual Growth Conference, with management scheduled to present on August 12, 2026, at 8:30 am ET. The live and archived webcast will be available at ir.telabio.com. TELA Bio specializes in innovative soft-tissue reconstruction solutions that prioritize patient anatomy preservation and minimize synthetic material exposure. For more information, visit www.telabi...
07-29 20:05
TELA Bio to Announce Second Quarter 2026 Financial Results
TELA Bio, Inc.宣布将于8月10日发布2026年第二季度财务报告。管理层将在当天下午4:30举办电话会议和网络直播，讨论财务结果并提供公司更新。TELA Bio专注于提供创新的软组织重建解决方案，旨在优化临床结果，强调保留和恢复患者的自身解剖结构。本文包含前瞻性陈述，这些陈述并非对未来业绩的保证。
07-20 20:05
TELA Bio posts modest Q1 growth, maintains 2026 outlook
An update from TELA Bio ( ($TELA) ) is now available. TELA Bio reported first q...
05-13 04:43
TELA Bio FY2026 Revenue expected to be more than $86.697M vs $86.849M Est
TELA Bio (NASDAQ:TELA) FY2026 Revenue expected to be more than $86.697M vs $86.849M Est
05-13 04:09
TELA Bio Sees Q2 Sales $20.000M vs $21.043M Est
TELA Bio (NASDAQ:TELA) sees Q2 sales of $20.000 million vs $21.043 million analyst estimate.
05-13 04:08
Earnings Scheduled For May 12, 2026
Companies Reporting Before The Bell • Sionna Therapeutics (NASDAQ:SION) is proj...
05-12 19:11
TELA Bio shares are trading higher after the company reported preliminary Q1 sales results above prior guidance. Also, the company replaced four board members.
TELA Bio shares are trading higher after the company reported preliminary Q1 sa...
05-02 01:59
美股大行评级 | 能源股再或大行青睐！康菲石油、雪铁龙、埃克森美孚、响尾蛇能源等获上调目标价；Unity评级分歧大，大摩、美银上调，富国银行下调
今日重点评级关注：花旗：维持Biomea Fusion"买入"评级，目标价从6美元升至7美元；Chardan Capital：维持Hyperion DeFi"买入"评级，目标价从7.75美元升至8.25美元
03-30 11:49
